Loading...
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
Therapeutic monoclonal antibodies have become molecules of choice to treat autoimmune disorders, inflammatory diseases, and cancer. Moreover, bispecific/multispecific antibodies that target more than one antigen or epitope on a target cell or recruit effector cells (T cell, natural killer cell, or m...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5266686/ https://ncbi.nlm.nih.gov/pubmed/28184223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00038 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|